Microsoft just turned 50 and there's no better time to revisit Windows logos. Here's a brief on Windows Logo evolution.

Lionsgate has just shared the official logo for The Hunger Games: Sunrise on the Reaping, which is the latest prequel in ...

Spider-Man: Brand New Day received its official logo reveal at the 2025 CinemaCon, generating buzz ahead of its 2026 release.

Saturday marked the 29-year anniversary of the Baltimore Ravens’ birth. With 2025 marking their 30th season, the AFC North club released an epic 30-year anniversary logo that includes references to ...

"Ravens gives us a strong nickname that is not common to teams at any level, and it gives one that means something, ...

Mercedes-Benz of Arrowhead, a premier luxury automotive dealership in Peoria, Arizona, is pleased to discuss the stunning new 2025 Mercedes-Benz GLE available in its inventory. This sophisticated SUV ...

Taxpayers are suing Arrowhead Union High School District officials, alleging misrepresentation in referendum information of renovation costs. The lawsuit claims the district has repeatedly sought ...

WE’RE STILL WORKING TO GET THAT INFORMATION TONIGHT. THE ARROWHEAD SCHOOL DISTRICT IN HEARTLAND IS ASKING VOTERS TO PASS A $136 MILLION REFERENDUM NEXT MONTH. NEW TONIGHT, 12 NEWS KENDALL KEYS ...

Expanding on the success of the MLB Debut Patch, Topps, Major League Baseball and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB ...

ARO-C3 showed a maximum mean C3 reduction of 89% and sustained reduction over 87% through 24 weeks in a Phase 1/2 study. The therapy reduced proteinuria, with a mean UPCR drop of 41% and a maximum ...

On Monday, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the company’s investigational RNA interference (RNAi) therapeutic ...

H.C. Wainwright reiterates a Buy rating and $80 price target on shares of Arrowhead (ARWR) Pharmaceuticals after the company announced top-line data from Part 2 of the Phase 1/2 trial evaluating ...